Next Article in Journal
Public Awareness about Medicine Information, Safety, and Adverse Drug Reaction (ADR) Reporting in Dammam, Saudi Arabia
Next Article in Special Issue
Towards Medicines Reuse: A Narrative Review of the Different Therapeutic Classes and Dosage Forms of Medication Waste in Different Countries
Previous Article in Journal
Knowledge and Attitudes of Student Pharmacists Regarding Polypharmacy and Deprescribing: A Cross-Sectional Study
Previous Article in Special Issue
Intentions to “Reuse” Medication in the Future Modelled and Measured Using the Theory of Planned Behavior
Review

Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste?

1
School of Management, Faculty of Management, Law and Social Sciences, University of Bradford, Bradford BD7 1DP, UK
2
School of Pharmacy and Medical Sciences, University of Bradford, Bradford BD7 1DP, UK
*
Author to whom correspondence should be addressed.
Pharmacy 2020, 8(4), 221; https://doi.org/10.3390/pharmacy8040221
Received: 31 August 2020 / Revised: 13 November 2020 / Accepted: 16 November 2020 / Published: 18 November 2020
(This article belongs to the Special Issue Medicines Reuse)
Background: The increase in pharmaceutical waste medicines is a global phenomenon and financial burden. The Circular Economy, as a philosophy within the pharmaceutical supply chain, aims to promote waste reduction, maximise medicines value, and enable sustainability within this supply chain (increasing circularity). Circularity strategies for pharmaceuticals are not currently implemented in many countries, due to quality and safety barriers. The aim of this study was to determine whether the application of circular economy principles can minimise pharmaceutical waste and support sustainability in the pharmaceutical supply chain; Methods: a detailed narrative literature review was conducted in order to examine pharmaceutical waste creation, management, disposal, and the application of circular economy principles; Results: the literature scrutinised revealed that pharmaceutical waste is created by multiple routes, each of which need to be addressed by pharmacists and healthcare bodies through the Circular Economy 9R principles. These principles act as a binding mechanism for disparate waste management initiatives. Medicines, or elements of a pharmaceutical product, can be better managed to reduce waste, cost, and reduce negative environmental impacts through unsafe disposal. Conclusions: the study findings outline a Circular Pharmaceutical Supply Chain and suggests that it should be considered and tested as a sustainable supply chain proposition. View Full-Text
Keywords: waste; reuse; reduce; pharmaceutical; medicines; hospital; circular economy waste; reuse; reduce; pharmaceutical; medicines; hospital; circular economy
Show Figures

Figure 1

MDPI and ACS Style

Alshemari, A.; Breen, L.; Quinn, G.; Sivarajah, U. Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste? Pharmacy 2020, 8, 221. https://doi.org/10.3390/pharmacy8040221

AMA Style

Alshemari A, Breen L, Quinn G, Sivarajah U. Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste? Pharmacy. 2020; 8(4):221. https://doi.org/10.3390/pharmacy8040221

Chicago/Turabian Style

Alshemari, Abdullah, Liz Breen, Gemma Quinn, and Uthayasankar Sivarajah. 2020. "Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste?" Pharmacy 8, no. 4: 221. https://doi.org/10.3390/pharmacy8040221

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop